echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Industry: in the medium and long term, we are still optimistic about the three main lines of the pharmaceutical industry

    Industry: in the medium and long term, we are still optimistic about the three main lines of the pharmaceutical industry

    • Last Update: 2020-02-05
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [pharmaceutical network pharmaceutical stock market] in recent years, the pharmaceutical sector highlights frequently, and the production and sales of relevant enterprises are expected to be large However, the industry also pointed out that in the medium and long term, the overall development trend of the pharmaceutical industry remains unchanged, and the main lines that are still optimistic include innovation industry chain, image diagnosis industry chain and consumer specialty chain medical industry chain Main line 1: innovation industry chain at present, with the continuous acceleration of policies such as volume purchase, high value consumables collection, medical insurance payment catalogue, innovative drugs, innovative devices and cro / CMO are favored In the aspect of innovative drugs, the leading enterprises with outstanding R & D ability and rich reserves are favored, which are supported by favorable policies, improved innovation enthusiasm In terms of innovative devices, domestic innovative medical devices are being imported and replaced The industry believes that in the future, with the promotion of DRGs, centralized purchase and other policies, it is expected to further improve the market share of leading enterprises In addition, cro / CMO industry is expected to maintain a high momentum under the cost advantage and the general trend of innovation and R & D of domestic enterprises Relevant securities personages suggest to pay attention to pharmaceutical stone technology, kailaiying, Kelun pharmaceutical, Wuxi apptec and Haichen pharmaceutical Main line 2: influenced by the spring breeze of policy, the development prospect of domestic medical image industry chain is optimistic in the industry Among them, "basic standards and management specifications of medical image diagnosis center (Trial)" encourages the use of information technology to promote the vertical flow of medical resources, and medical image diagnosis center provides remote image diagnosis and other services to grass-roots medical and health institutions, and mentions that "cooperation should be established with the regional level II and above general hospitals, to establish a green emergency channel for critical patients, and to strengthen Technical cooperation and continuous improvement of technical level " In recent years, with the upgrading of people's consumption level, the reform of medical image industry and the landing of hierarchical diagnosis and treatment, the medical image industry chain has great development space Relevant securities personage suggested to pay attention to Dongcheng pharmaceutical, the leader of nuclear medicine, sitari and Beilu pharmaceutical, the leader of iodine contrast agent As far as nuclear medicine is concerned, the data shows that in 2017, the domestic nuclear medicine market is about 4.382 billion yuan, and the CAGR from 2013 to 2017 is 12.1% It is estimated that the CAGR from 2018 to 2022 will be as high as 19.40%, which is in a high boom development stage China's nuclear medicine started late and has a huge development space Due to the high barriers of nuclear medicine industry, the competition pattern of Dongcheng pharmaceutical industry and China's co spoke and double oligarchs is present in China The industry believes that domestic nuclear medicine talents are scarce, and it is not easy to make high-quality nuclear medicine It takes five to ten years to re carve the current Dongcheng pharmaceutical industry, so the status of Dongcheng pharmaceutical industry is not easy to shake at present Main line 3: the national policy attaches great importance to big health, and the aging trend of the population is increasing, the level of people's consumption is improving, and the consumption oriented specialized medical chain is also favored It is understood that one of the major characteristics of the medical service specialty chain is that it takes 2-3 years to open a store in a unit store, and it will reach a mature period after continuous operation Different specialties will have different profit and loss models in the mature period Specialty chain can be divided into consumer medicine and rigid medicine according to major categories: consumer medicine refers to the specialty categories that people can choose independently, such as oral medicine, medical beauty and Ophthalmology; rigid medicine refers to the specialized medical services that consumers just need, such as orthopedics, cardiovascular, etc With the upgrading of the medical consumption track, relevant securities people suggest paying attention to the enterprises in the oral industry chain, such as Tongce medical, Zhenghai biology and Meiya optoelectronics.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.